PG/22/10989/BHF_/British Heart Foundation/United Kingdom[Grants and Funding] - Search Results

1

Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity.

Schmidt AF, Bourfiss M, Alasiri A, Puyol-Anton E, Chopade S, van Vugt M, van der Laan SW, Gross C, Clarkson C, Henry A, Lumbers TR, van der Harst P, Franceschini N, Bis JC, Velthuis BK, Te Riele ASJM, Hingorani AD, Ruijsink B, Asselbergs FW, van Setten J, Finan C. Schmidt AF, et al. Sci Adv. 2023 Apr 28;9(17):eadd4984. doi: 10.1126/sciadv.add4984. Epub 2023 Apr 26. Sci Adv. 2023. PMID: 37126556 Free PMC article.

2

Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance.

Sae-Jie W, Supasai S, Kivimaki M, Price JF, Wong A, Kumari M, Engmann J, Shah T, Schmidt AF, Gaunt TR, Hingorani A, Charoen P; UCLEB Consortium. Sae-Jie W, et al. BMC Med. 2023 Sep 4;21(1):340. doi: 10.1186/s12916-023-03047-7. BMC Med. 2023. PMID: 37667256 Free PMC article.

3

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog.

Hingorani AD, Gratton J, Finan C, Schmidt AF, Patel R, Sofat R, Kuan V, Langenberg C, Hemingway H, Morris JK, Wald NJ. Hingorani AD, et al. BMJ Med. 2023 Oct 17;2(1):e000554. doi: 10.1136/bmjmed-2023-000554. eCollection 2023. BMJ Med. 2023. PMID: 37859783 Free PMC article.

4

Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy.

Muller SA, Gasperetti A, Bosman LP, Schmidt AF, Baas AF, Amin AS, Houweling AC, Wilde AAM, Compagnucci P, Targetti M, Casella M, Calò L, Tondo C, van der Harst P, Asselbergs FW, van Tintelen JP, Oerlemans MIFJ, Te Riele ASJM. Muller SA, et al. J Am Coll Cardiol. 2023 Jul 18;82(3):214-225. doi: 10.1016/j.jacc.2023.05.005. Epub 2023 May 18. J Am Coll Cardiol. 2023. PMID: 37210036 Free article.

5

Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis.

Schmidt A, Finan C, Bourfiss M, Velthuis B, Puyol-Antón E, Alasiri A, Ruijsink B, Asselbergs F, Ter Riele A, van Setten J. Schmidt A, et al. Res Sq [Preprint]. 2023 Feb 2:rs.3.rs-2449265. doi: 10.21203/rs.3.rs-2449265/v1. Res Sq. 2023. PMID: 36778476 Free PMC article. Preprint.

6

DCM-PROGRESS: predicting end-stage heart failure in non-ischemic dilated cardiomyopathy patients.

Schmidt AF, Leinveber P, Panovsky R, Soukup L, Machac P, van de Leur RR, Sammani A, Lekadir K, Ter Riele A, Asselbergs FW, Boonstra MJ. Schmidt AF, et al. medRxiv [Preprint]. 2023 Sep 11:2023.09.10.23295251. doi: 10.1101/2023.09.10.23295251. medRxiv. 2023. PMID: 37745419 Free PMC article. Preprint.

7

Prospective associations between diet quality, dietary components, and risk of cardiometabolic multimorbidity in older British men.

Wang Q, Schmidt AF, Lennon LT, Papacosta O, Whincup PH, Wannamethee SG. Wang Q, et al. Eur J Nutr. 2023 Oct;62(7):2793-2804. doi: 10.1007/s00394-023-03193-x. Epub 2023 Jun 19. Eur J Nutr. 2023. PMID: 37335359 Free PMC article.

8

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers.

Jansen M, Schmidt AF, Jans JJM, Christiaans I, van der Crabben SN, Hoedemaekers YM, Dooijes D, Jongbloed JDH, Boven LG, Lekanne Deprez RH, Wilde AAM, van der Velden J, de Boer RA, van Tintelen JP, Asselbergs FW, Baas AF. Jansen M, et al. J Cardiovasc Transl Res. 2023 Dec;16(6):1267-1275. doi: 10.1007/s12265-023-10398-2. Epub 2023 Jun 6. J Cardiovasc Transl Res. 2023. PMID: 37278928 Free PMC article.

9

Sex-specific Mendelian randomisation to assess the causality of sex differences in the effects of risk factors and treatment: spotlight on hypertension.

de Ruiter SC, Schmidt AF, Grobbee DE, den Ruijter HM, Peters SAE. de Ruiter SC, et al. J Hum Hypertens. 2023 Aug;37(8):602-608. doi: 10.1038/s41371-023-00821-1. Epub 2023 Apr 7. J Hum Hypertens. 2023. PMID: 37024639 Free PMC article. Review.

10

Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders.

Schmidt AF, Finan C, Chopade S, Ellmerich S, Rossor MN, Hingorani AD, Pepys MB. Schmidt AF, et al. medRxiv [Preprint]. 2023 Aug 16:2023.08.15.23293564. doi: 10.1101/2023.08.15.23293564. medRxiv. 2023. Update in: Open Biol. 2024 Jul;14(7):230419. doi: 10.1098/rsob.230419. PMID: 37645746 Free PMC article. Updated. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters